Earlydx
1 known investors
EarlyDiagnostics (EarlyDx) develops blood tests and bioinformatics tools that analyze cell-free DNA methylation via its MethylScan platform for early disease detection, cancer screening, risk stratification, and treatment monitoring. It offers products including the CancerRadar blood test and the EarlyDx-Cloud liquid biopsy bioinformatics solution for diagnostic companies.
AI & Machine LearningBiotechDigital Health